Cancer trial drug may work differently than scientists believed, raising concerns for clinical research
A cancer drug currently being tested in patients may have entered clinical trials based on an incorrect understanding of how it works, according to a new study led by the University of Sydney in collaboration with Goethe University, Oxford University and the Institute of Cancer Research, London.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
